April 30, 2020 / 11:51 AM / a month ago

BRIEF-InMed Receives Cta Approval For Second Phase 1 Clinical Trial With INM-755

April 30 (Reuters) - InMed Pharmaceuticals Inc:

* INMED RECEIVES CTA APPROVAL FOR SECOND PHASE 1 CLINICAL TRIAL WITH INM-755 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below